Function of human cytochrome P450s: characterization of the orphans.

The human genome has now been established to contain 57 cytochrome P450 genes. The proteins can be grouped into categories of types of substrates, including sterols, fatty acids, eicosanoids, and fat-soluble vitamins. Some P450s have also been demonstrated to have significant roles in the metabolism of drugs and chemicals. In addition to these, at least 13 can be considered to still be without apparent function with endogenous or xenobiotic substrates. The current list includes P450s 2A7, 2S1, 2U1, 2W1, 3A43, 4A22, 4F11, 4F22, 4V2, 4X1, 4Z1, 20A1, and 27C1. Limited information is available about the sites of mRNA expression of some of these orphans. Some strategies for characterization are discussed.

[1]  K. Anderson,et al.  Radiometric analysis of biological oxidations in man: sex differences in estradiol metabolism. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[2]  M. Kaiser-Kupfer,et al.  Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2. , 2004, American journal of human genetics.

[3]  M. Waterman,et al.  Characterization of the CYP4A11 gene, a second CYP4A gene in humans. , 2003, Archives of biochemistry and biophysics.

[4]  M. Butler,et al.  Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Brockmöller,et al.  Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[6]  F. Gonzalez,et al.  The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. , 1990, Biochemistry.

[7]  Jun-yan Hong,et al.  HUMAN CYTOCHROME P450 2S1: LACK OF ACTIVITY IN THE METABOLIC ACTIVATION OF SEVERAL CIGARETTE SMOKE CARCINOGENS AND IN THE METABOLISM OF NICOTINE , 2005, Drug Metabolism and Disposition.

[8]  H. Strobel,et al.  Expression and characterization of human cytochrome P450 4F11: Putative role in the metabolism of therapeutic drugs and eicosanoids. , 2004, Toxicology and applied pharmacology.

[9]  A. Fersht.  Structure and mechanism in protein science , 1998 .

[10]  F. Guengerich,et al.  Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. , 2001, Chemical research in toxicology.

[11]  F. Guengerich,et al.  Cytochrome P450 3A4-catalyzed Testosterone 6β-Hydroxylation Stereochemistry, Kinetic Deuterium Isotope Effects, and Rate-limiting Steps* , 2005, Journal of Biological Chemistry.

[12]  M. Ingelman-Sundberg,et al.  Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity , 2002, Human mutation.

[13]  J. Schenkman,et al.  Expression patterns of mouse and human CYP orthologs (families 1-4) during development and in different adult tissues. , 2005, Archives of biochemistry and biophysics.

[14]  H. Cui,et al.  Liver-specific Deletion of the NADPH-Cytochrome P450 Reductase Gene , 2003, Journal of Biological Chemistry.

[15]  E. Rieber,et al.  Identification of a Novel Mammary-Restricted Cytochrome P450, CYP4Z1, with Overexpression in Breast Carcinoma , 2004, Cancer Research.

[16]  T. Rebbeck,et al.  CYP3A4, CYP3A5, and CYP3A43 Genotypes and Haplotypes in the Etiology and Severity of Prostate Cancer , 2004, Cancer Research.

[17]  J. Halpert,et al.  cDNA cloning and initial characterization of CYP3A43, a novel human cytochrome P450. , 2001, Molecular pharmacology.

[18]  D. Waxman,et al.  Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. , 1986, The Journal of biological chemistry.

[19]  M. Taimi,et al.  CYP2U1, a Novel Human Thymus- and Brain-specific Cytochrome P450, Catalyzes ω- and (ω-1)-Hydroxylation of Fatty Acids* , 2004, Journal of Biological Chemistry.

[20]  J. Schenkman,et al.  Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. , 2003, Archives of biochemistry and biophysics.

[21]  Eric F. Johnson,et al.  Differential regulation of human CYP4A genes by peroxisome proliferators and dexamethasone. , 2003, Archives of biochemistry and biophysics.

[22]  J. Lafitte,et al.  First report of a genetic polymorphism of the cytochrome P450 3A43 (CYP3A43) gene: Identification of a loss‐of‐function variant , 2004, Human mutation.

[23]  Eric F. Johnson,et al.  Conditional regulation of the human CYP4X1 and CYP4Z1 genes. , 2005, Archives of biochemistry and biophysics.

[24]  F. Guengerich,et al.  Cooperativity in oxidations catalyzed by cytochrome P450 3A4. , 1997, Biochemistry.

[25]  M. Ingelman-Sundberg,et al.  Cloning and tissue distribution of a novel human cytochrome p450 of the CYP3A subfamily, CYP3A43. , 2001, Biochemical and biophysical research communications.

[26]  D. Kelly,et al.  The Diversity and Importance of Microbial Cytochromes P450 , 2005 .

[27]  D. Harder,et al.  Identification of a novel cytochrome P450, CYP4X1, with unique localization specific to the brain. , 2002, Biochemical and biophysical research communications.

[28]  M Ingelman-Sundberg,et al.  Identification and tissue distribution of the novel human cytochrome P450 2S1 (CYP2S1). , 2001, Biochemical and biophysical research communications.

[29]  William B. Jakoby,et al.  Enzymatic basis of detoxication , 1980 .

[30]  O. Hankinson,et al.  Identification of a novel dioxin-inducible cytochrome P450. , 2002, Molecular pharmacology.

[31]  R. Evans,et al.  The RXR heterodimers and orphan receptors , 1995, Cell.

[32]  A. Hayes.  Principles and methods of toxicology , 1982 .

[33]  D. Kroetz,et al.  REGULATION AND INHIBITION OF ARACHIDONIC ACID ω-HYDROXYLASES AND 20-HETE FORMATION , 2005 .

[34]  F. Gonzalez,et al.  Study of P450 function using gene knockout and transgenic mice. , 2003, Archives of biochemistry and biophysics.

[35]  K. Husgafvel‐Pursiainen,et al.  Identification of genetic polymorphisms of CYP2S1 in a Finnish Caucasian population. , 2004, Mutation research.

[36]  M. Ingelman-Sundberg,et al.  Characterization and tissue distribution of a novel human cytochrome P450-CYP2U1. , 2004, Biochemical and biophysical research communications.

[37]  F. Guengerich,et al.  Human cytochrome P-450 enzymes. , 1992, Life sciences.

[38]  Ortiz de Montellano,et al.  Cytochrome P-450: Structure, Mechanism, and Biochemistry , 1986 .

[39]  R. Tyndale,et al.  Implications of CYP2A6 Genetic Variation for Smoking Behaviors and Nicotine Dependence , 2005, Clinical pharmacology and therapeutics.

[40]  C. Wolf,et al.  Inactivation of the Hepatic Cytochrome P450 System by Conditional Deletion of Hepatic Cytochrome P450 Reductase* , 2003, The Journal of Biological Chemistry.

[41]  D. Liebler,et al.  P-Mod: an algorithm and software to map modifications to peptide sequences using tandem MS data. , 2005, Journal of proteome research.

[42]  B. Møller,et al.  Cytochrome P450s in Plants , 2005 .

[43]  M. Sarfarazi,et al.  Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21. , 1997, Human molecular genetics.

[44]  H. Yamazaki,et al.  Aryl hydrocarbon hydroxylase represents CYP1B1, and not CYP1A1, in human freshly isolated white cells: trimodal distribution of Japanese population according to induction of CYP1B1 mRNA by environmental dioxins. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[45]  Gillian Smith,et al.  Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases , 2003, The Lancet.

[46]  D. Russell,et al.  Clinical importance of the cytochromes P450 , 2002, The Lancet.

[47]  B. Lake,et al.  Expression and alternative splicing of the cytochrome P-450 CYP2A7. , 1995, The Biochemical journal.